Navigation Bar (1k)

James F. Hainfeld


Updated: January 24, 2005

Dr. James F. Hainfeld is the President/CEO and founder of Nanoprobes. He has pioneered the use of metal nanoparticles as labels and probes for biological structures and processes for over twenty years, and first introduced gold clusters as immunolabels. Nanoparticles containing gold, iridium, tungsten, uranium, platinum and silver were adapted for use in biological systems. Many of these were studied at the molecular level and by electron microscopy. He co-developed with Vice President Frederic Furuya the very useful Nanogold cluster. He also discovered Enzyme Metallography, a sensitive detection method using enzymes to deposit metals, now being used in clinical cancer tests.

Dr. Hainfeld holds a B.S.E. (Electrical Engineering) from Princeton University and a Ph.D. (Chemistry / Biochemistry) from the University of Texas at Austin where he worked with D. J. DeRosier and L. J. Reed, and was a postdoctoral fellow with A. V. Crewe and T. L. Steck (Biophysics/Biology) at the University of Chicago. He then joined the Biology Department at Brookhaven National Laboratory in 1976.

Dr. Hainfeld was nationally elected to serve as Counsellor to The Histochemical Society, and is on the Editorial Board of the Journal of Histochemistry and Cytochemistry. His experience includes synthetic chemistry, molecular biology, immunocytochemistry, in situ hybridization, electron and light microscopy, NMR, cell culture, implantation of tumors in mice, tail vein injections, dissections, biodistribution studies, and analytic techniques, such as FTIR, mass and atomic absorption spectrometry. He has conducted radioimmunotherapy studies using radioactive gold clusters, and use of natural gold nanoparticles in Photon Activated Therapy. His interests also include MRI, where he has synthesized novel magnetic nanoparticle contrast agents. His current research is focused on medical uses of metal nanoparticles as contrast agents for X-ray and MRI for heart disease and tumor detection, use of nanoparticles for cancer therapy, development of new labels for light and electron microscopy, sensitive detection methods, and fusion protein drug development. He has obtained 11 patents and has over 100 reviewed publications.

Our Fearless Leader... (32k)

Dr. Hainfeld also holds joint appointments at Brookhaven National Laboratory and as Adjunct Professor at Stony Brook University (State University of New York).

E-mail Dr. Hainfeld at hainfeld@nanoprobes.com


Recent Publications


Navigation Bar (1k)
© 1997, 2001 Nanoprobes, Incorporated. All rights reserved.